packageLapatinib

lapatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lapatinib is a HER2-targeting protein kinase inhibitor used to treat certain breast cancers, including rare breast tumors. It is approved and authorised in the European Union for breast cancer, and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q420323 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lapatinib
ATC codes:L01EH01
DrugBank:DB01259
PubChem CID:208908
ChEBI:49603
Wikidata:Q420323
formula:C29H26ClFN4O4S
molar mass:581.059 g/mol (PubChem CID 208908)
logP:5.1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown